作者
Steve Morgan, Paul Grootendorst, Joel Lexchin, Colleen Cunningham, Devon Greyson
发表日期
2011/4/1
来源
Health policy
卷号
100
期号
1
页码范围
4-17
出版商
Elsevier
简介
OBJECTIVES
We aimed to systematically review and assess published estimates of the cost of developing new drugs.
METHODS
We sought English language research articles containing original estimates of the cost of drug development that were published from 1980 to 2009, inclusive. We searched seven databases and used citation tracing and expert referral to identify studies. We abstracted qualifying studies for information about methods, data sources, study samples, and key results.
RESULTS
Thirteen articles were found to meet our inclusion criteria. Estimates of the cost of drug development ranged more than 9-fold, from USD 92millioncash(USD 161 million capitalized) to USD 883.6millioncash(USD 1.8 billion capitalized). Differences in methods, data sources, and time periods explain some of the variation in estimates. Lack of transparency limits many studies. Confidential information provided by …
引用总数
20112012201320142015201620172018201920202021202220232024325336242556254787569595135
学术搜索中的文章
S Morgan, P Grootendorst, J Lexchin, C Cunningham… - Health policy, 2011